Shahryar Yadegar, M.D. Internal Medicine - Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 18399 Ventura Blvd, Suite 245, Tarzana, CA 91356 Phone: 818-609-7536 Fax: 818-344-9670 |
News Archive
This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.
The program, set up by Advocate, covers 380,000 enrollees, the Chicago Sun-Times reports. Meanwhile, other outlets look at health law implementation efforts in Massachusetts and California.
Shire plc and Parion Sciences, Inc. have announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investigational epithelial sodium channel (ENaC) inhibitor for the potential treatment of dry eye disease in adults, with the opportunity for Parion to co-fund.
FK506 possesses a well-studied neuroregenerative effect, stimulating neurite extension in the presence of nerve growth factor in vitro, and enhancing nerve regeneration following nerve crush injury and isografting.
Changes to the gut microbiome interacted with the immune system to slow the growth of cancer in mice exposed to cigarette smoke, according to research that was selected for presentation at Digestive Disease Week 2020.
› Verified 9 days ago